CTI Hires Battelle to Facilitate FDA Submission
LAYTON, Utah, June 1 -- Computerized Thermal Imaging, Inc. (CTI) has retained Battelle Medical Products to assist with the formal FDA approval process for CTI's Thermal Breast Imaging System. We decided to retain the services of Battelle Medical Products because there is nothing more critical for this company than to successfully complete the submission of clinical data to the FDA as quickly and expeditiously as possible, said David A. Packer, president of CTI. Battelle is one of the most respected technology companies in the world, having delivered technology-based value to industry and government for nearly 70 years. We believe that by having them as part of our team, we will be able to avoid many of the pitfalls that might cause unanticipated delays in the approval process.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024